Observational Study on the Use of NovoSeven® for Haemostatic Treatment of Bleeding Episodes in Patients With Acquired Haemophilia

Clinical trial NCT01285089 · COMPLETED

Trial details

NCT number: NCT01285089
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Study type: OBSERVATIONAL

Acquired Bleeding Disorder Acquired Haemophilia

Start date: 2010-12-01
Primary completion: 2013-10-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.